Express Scripts sees slow 2016 sales for new cholesterol drugs
February 12, 2016 at 15:02 PM EST
NEW YORK, Feb 12 (Reuters) - A surge in sales of pricey new cholesterol treatments is unlikely to materialize this year, contrary to the previous expectations of Express Scripts Holding , an executive from the largest manager of U.S. drug benefits said on Friday.